Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 21,655,184 | 20,349,724 | 21,413,280 | 21,212,000 | 20,534,030 |
| Cost of Goods | 4,763,187 | 4,306,955 | 4,538,240 | 4,609,000 | 4,439,772 |
| Gross Profit | 16,891,997 | 16,042,769 | 16,875,040 | 16,603,000 | 16,094,259 |
| Operating Expenses | 16,528,190 | 9,895,413 | 10,491,600 | 9,909,000 | 9,991,035 |
| Operating Income | 363,806 | 6,147,356 | 6,383,440 | 6,694,000 | 6,103,224 |
| Interest Expense | N/A | N/A | N/A | 206,000 | N/A |
| Other Income | 6,366,608 | -31,282 | -62,720 | -982,000 | -17,894 |
| Pre-tax Income | 6,730,414 | 6,116,074 | 6,320,720 | 5,506,000 | 6,085,330 |
| Income Tax | 1,915,503 | 1,700,155 | 1,736,560 | 1,461,000 | 1,650,376 |
| Net Income Continuous | 4,687,637 | 4,300,177 | 4,478,320 | 4,045,000 | 4,434,954 |
| Net Income Extraordinary | N/A | N/A | N/A | N/A | -1,335,166 |
| Minority Interests | -126,693 | -115,742 | -94,080 | -110,000 | -97,040 |
| Net Income | $4,687,637 | $4,300,177 | $4,478,320 | $3,935,000 | $3,099,788 |
| EPS Basic Total Ops | 1.03 | 0.94 | 0.97 | 0.83 | 0.63 |
| EPS Basic Continuous Ops | 1.03 | 0.94 | 0.97 | 0.83 | 0.63 |
| EPS Diluted Total Ops | 1.02 | 0.94 | 0.96 | 0.83 | 0.63 |
| EPS Diluted Continuous Ops | 1.02 | 0.94 | 0.96 | 0.83 | 0.63 |
| EBITDA(a) | $1,267,510 | $7,037,839 | $7,242,480 | $6,536,000 | $6,916,023 |